Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies

Encouraging results from recent clinical trials are revitalizing the field of oncolytic virotherapies. Human adenovirus type 5 (HAdV-C5/Ad5) is a common vector for its ease of manipulation, high production titers and capacity to transduce multiple cell types. However, effective clinical applications...

Descripción completa

Detalles Bibliográficos
Autores principales: Uusi-Kerttula, Hanni, Davies, James, Coughlan, Lynda, Hulin-Curtis, Sarah, Jones, Rachel, Hanna, Louise, Chester, John D., Parker, Alan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053699/
https://www.ncbi.nlm.nih.gov/pubmed/27056886
http://dx.doi.org/10.18632/oncotarget.8545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053699/
https://www.ncbi.nlm.nih.gov/pubmed/27056886
http://dx.doi.org/10.18632/oncotarget.8545

Ejemplares similares